210 related articles for article (PubMed ID: 20140868)
1. [Histone deacetylase inhibitors as therapeutic agents for polyglutamine disorders].
Jiang H; Jia D; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):52-5. PubMed ID: 20140868
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.
Butler R; Bates GP
Nat Rev Neurosci; 2006 Oct; 7(10):784-96. PubMed ID: 16988654
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases.
Sharma S; Taliyan R
Pharmacol Res; 2015 Oct; 100():157-69. PubMed ID: 26254871
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: Histone modifications in Huntington's disease.
Sadri-Vakili G; Cha JH
Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
[TBL] [Abstract][Full Text] [Related]
6. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
Ganai SA; Banday S; Farooq Z; Altaf M
Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
8. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death).
Sadri-Vakili G; Cha JH
Curr Alzheimer Res; 2006 Sep; 3(4):403-8. PubMed ID: 17017871
[TBL] [Abstract][Full Text] [Related]
10. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?
Grayson DR; Kundakovic M; Sharma RP
Mol Pharmacol; 2010 Feb; 77(2):126-35. PubMed ID: 19917878
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors: biology and mechanism of action.
Mehnert JM; Kelly WK
Cancer J; 2007; 13(1):23-9. PubMed ID: 17464243
[TBL] [Abstract][Full Text] [Related]
12. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida M; Shimazu T; Matsuyama A
Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
[TBL] [Abstract][Full Text] [Related]
13. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
14. HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy.
Hamamori Y; Schneider MD
J Clin Invest; 2003 Sep; 112(6):824-6. PubMed ID: 12975465
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases.
Edwards AJ; Pender SL
Biochem Soc Trans; 2011 Aug; 39(4):1092-5. PubMed ID: 21787354
[TBL] [Abstract][Full Text] [Related]
16. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of airway inflammation.
Adcock IM; Tsaprouni L; Bhavsar P; Ito K
Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
[TBL] [Abstract][Full Text] [Related]
18. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the discovery of small molecule histone deacetylase inhibitors.
Remiszewski SW
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):487-99. PubMed ID: 12197307
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases, transcriptional control, and cancer.
Cress WD; Seto E
J Cell Physiol; 2000 Jul; 184(1):1-16. PubMed ID: 10825229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
